Skip to main content
. 2019 Aug 17;20(16):4012. doi: 10.3390/ijms20164012
PCa prostate cancer
PSA prostate-specific antigen
RP radical prostatectomy
RT radiation therapy
ECM extracellular matrix
CDH1 E-cadherin
EMT epithelial to mesenchymal transition
lncRNAs long non-coding RNAs
ER estrogen receptor
eNOS endothelial nitric oxide synthase
HIFs hypoxia inducible factors
HOTS H19 Opposite Tumor Suppressor
E2 17β-estradiol
HYP hypoxia
CoCl2 cobalt chloride
qPCR quantitative polymerase chain reaction
KDR vascular endothelial growth factor receptor 2
EPO erythropoietin
ChIP chromatin immunoprecipitation
TSS transcriptional start site
HDAC histone deacetylases
VHL von Hippel-Lindau tumor suppressor
Ca2+ calcium
ITGB3 β3 integrin subunit
ITGB4 β4 integrin subunit
ITGA2 α2 integrin subunit
RUNX2 Runt-related transcription factor 2
H3K27me3 trimethylated lysine 27 of histone H3
OSCs organotypic slice cultures
CCND1 Cyclin D1
RNA-ChIP RNA chromatin immunoprecipitation
DMSO dimethyl sulfoxide
EDTA ethylenediaminetetraacetic acid
PBS phosphate-buffered saline